Research programme: ergothioneine - OXIS International/University of Colorado
Alternative Names: Research programme: ergothioneine - OXIS International - University of Colorado (JV)Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator University of Colorado at Denver
- Class Amino acids
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Acute lung injury
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Acute-lung-injury in USA
- 11 Jul 2011 Preclinical trials in Acute lung injury in USA (unspecified route)